drugset / Trial / NCT00882687

Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis

NCT00882687

Phase 2 Completed 60 enrolled Shire
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine whether SAR 1118 at three different concentrations, compared to placebo, is effective in the prevention of the signs and symptoms of allergic conjunctivitis

Timeline

Start
2009-04-24
Primary completion
2009-05-10
Completion
2009-05-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lifitegrast Unknown 0.1 %
Subject Lifitegrast Unknown 1 %
Subject Lifitegrast Unknown 5 %

Indications